SRT2104 (GSK2245840)

Cat. No.: OB0225WX-2707

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and HPLC.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: SRT2104 (GSK2245840) is a selective molecular activator of SIRT1 that plays a key role in the biochemical regulation of energy homeostasis.

Synonym: 1093403-33-8; SRT2104; SRT 2104; SRT-2104; 4-Methyl-n-(2-(3-(morpholinomethyl)imidazo[2,1-b]thiazol-6-yl)phenyl)-2-(pyridin-3-yl)thiazole-5-carboxamide; 5-Thiazolecarboxamide, 4-methyl-N-[2-[3-(4-morpholinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-(3-pyridinyl)-; 4-Methyl-N-(2-{3-[(morpholin-4-yl)methyl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl)-2-(pyridin-3-yl)-1,3-thiazole-5-carboxamide; 4-Methyl-N-[2-[3-(morpholin-4-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2-pyridin-3-yl-1,3-thiazole-5-carboxamide; 4-Methyl-N-[2-[3-(morpholinomethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-(pyridin-3-yl)thiazole-5-carboxamide

CAS No.: 1093403-33-8

Compound CID: 25108829

Formula: C₂₆H₂₄N₆O₂S₂

Formula Weight: 516.64

Specification

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: SRT2104 (GSK2245840) is employed in metabolic and aging research as a selective SIRT1 activator to investigate the enhancement of mitochondrial function and the regulation of metabolic homeostasis.